Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellectis S.A. reports on the Combined General Meeting of Shareholders held on June 28, 2024. The document serves to disclose the voting results of this meeting to the U.S. Securities and Exchange Commission.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance proceedings and does not contain financial statements or operational metrics.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The document focuses solely on the procedural outcome of the shareholder meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, risk factors, contingencies, or unusual items. It strictly incorporates the voting results of the June 28, 2024 meeting by reference.
Key Facts for Investors
- The Combined General Meeting of Shareholders took place on June 28, 2024.
- Voting results are attached as Exhibit 99.1 and incorporated by reference.
- The report was signed by André Choulika, Chief Executive Officer.
- No financial data or operational updates are included in this specific filing.